SIMILAR PATTERNS OF AMINO ACIDS FOR 3NBR_A_ASDA129

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hg3 TRIOSEPHOSPHATE
ISOMERASE

(Pyrococcus
woesei) 		PF00121
(TIM)
PF05690
(ThiG) 		5 SER A  57
VAL A  62
VAL A  44
PRO A  46
PHE A  13
 None
 1.05A 3nbrA-1hg3A:
undetectable		 3nbrA-1hg3A:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qd9 PURINE REGULATORY
PROTEIN YABJ

(Bacillus
subtilis) 		PF01042
(Ribonuc_L-PSP) 		5 SER A  29
PHE A  95
VAL A  71
VAL A  72
PRO A 100
 None
 1.38A 3nbrA-1qd9A:
0.0		 3nbrA-1qd9A:
24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2k87 NON-STRUCTURAL
PROTEIN 3 OF
REPLICASE
POLYPROTEIN 1A

(Severe acute
respiratory
syndrome-related
coronavirus) 		PF16251
(NAR) 		5 ASN A 101
VAL A  62
VAL A  52
MET A  39
PHE A  32
 None
 1.48A 3nbrA-2k87A:
0.0		 3nbrA-2k87A:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ecq ENDO-ALPHA-N-ACETYLG
ALACTOSAMINIDASE

(Streptococcus
pneumoniae) 		PF12905
(Glyco_hydro_101)
PF17451
(Glyco_hyd_101C) 		5 SER A 449
PHE A 347
VAL A 410
PRO A 348
PHE A 421
 None
 1.48A 3nbrA-3ecqA:
0.0		 3nbrA-3ecqA:
6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gzg PERMEASE
MOLYBDATE-BINDING
PERIPLASMIC PROTEIN

(Xanthomonas
citri) 		PF13531
(SBP_bac_11) 		5 PHE A 225
SER A  16
VAL A  34
VAL A  32
PHE A 212
 None
 1.09A 3nbrA-3gzgA:
0.0		 3nbrA-3gzgA:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lyg NTF2-LIKE PROTEIN OF
UNKNOWN FUNCTION

(Colwellia
psychrerythraea) 		PF12680
(SnoaL_2) 		5 PHE A 119
VAL A 118
PRO A  59
MET A  34
PHE A  62
 None
None
None
None
UNL  A 121 ( 4.9A)
 1.20A 3nbrA-3lygA:
13.7		 3nbrA-3lygA:
25.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3owu STEROID
DELTA-ISOMERASE

(Pseudomonas
putida) 		PF12680
(SnoaL_2) 		5 TYR A  16
ASN A  40
PHE A  56
VAL A  88
MET A 116
 EQU  A 200 (-4.5A)
EQU  A 200 (-3.5A)
None
None
EQU  A 200 (-4.9A)
 0.46A 3nbrA-3owuA:
21.2		 3nbrA-3owuA:
34.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pie 5'->3'
EXORIBONUCLEASE
(XRN1)

(Kluyveromyces
lactis) 		PF03159
(XRN_N) 		5 SER A1198
VAL A1187
PHE A1164
VAL A1170
PHE A1203
 None
 1.37A 3nbrA-3pieA:
0.0		 3nbrA-3pieA:
7.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q6g HEAVY CHAIN OF FAB
OF RHESUS MAB 2.5B
LIGHT CHAIN OF FAB
OF RHESUS MAB 2.5B

(Macaca mulatta) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.37A 3nbrA-3q6gH:
0.0		 3nbrA-3q6gH:
16.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t8u STEROID
DELTA-ISOMERASE

(Comamonas
testosteroni) 		PF12680
(SnoaL_2) 		5 PHE A  54
SER A  58
PHE A  82
VAL A  65
MET A 112
 None
 1.49A 3nbrA-3t8uA:
23.9		 3nbrA-3t8uA:
96.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t8u STEROID
DELTA-ISOMERASE

(Comamonas
testosteroni) 		PF12680
(SnoaL_2) 		9 PHE A  54
SER A  58
PHE A  82
VAL A  84
PHE A  86
VAL A  95
PRO A  97
MET A 112
PHE A 116
 None
 0.57A 3nbrA-3t8uA:
23.9		 3nbrA-3t8uA:
96.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4af3 AURORA KINASE B

(Homo sapiens) 		PF00069
(Pkinase) 		5 PHE A 273
VAL A 268
VAL A 296
PRO A 293
PHE A 292
 None
 1.21A 3nbrA-4af3A:
undetectable		 3nbrA-4af3A:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dqv PROBABLE PEPTIDE
SYNTHETASE NRP
(PEPTIDE SYNTHASE)

(Mycobacterium
tuberculosis) 		PF07993
(NAD_binding_4) 		5 TYR A 228
SER A 153
PHE A 253
VAL A 337
ASN A 158
 None
 1.34A 3nbrA-4dqvA:
undetectable		 3nbrA-4dqvA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fh8 ACEPRX-1

(Ancylostoma
ceylanicum) 		PF00578
(AhpC-TSA)
PF10417
(1-cysPrx_C) 		5 TYR A  41
PHE A  45
SER A  80
VAL A  18
PHE A  23
 None
 1.37A 3nbrA-4fh8A:
undetectable		 3nbrA-4fh8A:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gdl AUTOPHAGY PROTEIN 5

(Homo sapiens) 		PF04106
(APG5) 		5 PHE B 165
VAL B  42
PRO B 261
ASN B 169
MET B 173
 None
 1.47A 3nbrA-4gdlB:
undetectable		 3nbrA-4gdlB:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4glr ANTI-PTAU HEAVY
CHAIN
ANTI-PTAU LIGHT
CHAIN

(Gallus gallus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 166
VAL I 195
VAL I 144
PRO I 113
PHE I 139
 None
 1.36A 3nbrA-4glrH:
undetectable		 3nbrA-4glrH:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jy6 PGT123 HEAVY CHAIN
PGT123 LIGHT CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE B 164
SER A 179
VAL A 150
VAL A 148
PHE A 143
 None
 1.31A 3nbrA-4jy6B:
undetectable		 3nbrA-4jy6B:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ktd GE136 HEAVY CHAIN
FAB
GE136 LIGHT CHAIN
FAB

(Macaca mulatta) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.38A 3nbrA-4ktdH:
undetectable		 3nbrA-4ktdH:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kw6 PEROXIREDOXIN-1

(Ancylostoma
ceylanicum) 		PF00578
(AhpC-TSA) 		5 TYR A  41
PHE A  45
SER A  80
VAL A  18
PHE A  23
 None
 1.35A 3nbrA-4kw6A:
undetectable		 3nbrA-4kw6A:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lsu HEAVY CHAIN OF
ANTIBODY VRC-PG20
LIGHT CHAIN OF
ANTIBODY VRC-PG20

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.47A 3nbrA-4lsuH:
undetectable		 3nbrA-4lsuH:
18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o9x TCDB2, TCCC3

(Photorhabdus
luminescens) 		PF03534
(SpvB)
PF12255
(TcdB_toxin_midC)
PF12256
(TcdB_toxin_midN) 		5 VAL A1492
PHE A1490
VAL A1528
PRO A1526
PHE A1543
 None
 1.37A 3nbrA-4o9xA:
undetectable		 3nbrA-4o9xA:
4.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rnr PGT130 HEAVY CHAIN
PGT130 LIGHT CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE A 166
VAL B 195
VAL B 144
PRO B 113
PHE B 139
 None
 1.41A 3nbrA-4rnrA:
undetectable		 3nbrA-4rnrA:
17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4v3d ENDOTHELIAL PROTEIN
C RECEPTOR
HB3VAR03 CIDRA
DOMAIN

(Homo sapiens;
Plasmodium
falciparum) 		PF03011
(PFEMP)
PF16497
(MHC_I_3) 		5 TYR B  72
PHE A 656
PHE B 114
VAL B 116
PHE B 123
 PTY  B 200 (-3.6A)
PTY  B 200 ( 4.9A)
PTY  B 200 ( 4.9A)
PTY  B 200 (-4.9A)
PTY  B 200 ( 4.4A)
 1.46A 3nbrA-4v3dB:
undetectable		 3nbrA-4v3dB:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4v3d ENDOTHELIAL PROTEIN
C RECEPTOR
HB3VAR03 CIDRA
DOMAIN

(Homo sapiens;
Plasmodium
falciparum) 		PF03011
(PFEMP)
PF16497
(MHC_I_3) 		5 TYR B  72
PHE A 656
PHE B 114
VAL B 116
VAL B 124
 PTY  B 200 (-3.6A)
PTY  B 200 ( 4.9A)
PTY  B 200 ( 4.9A)
PTY  B 200 (-4.9A)
None
 1.39A 3nbrA-4v3dB:
undetectable		 3nbrA-4v3dB:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo sapiens) 		no annotation 5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.36A 3nbrA-4ydjH:
undetectable		 3nbrA-4ydjH:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yo0 HEAVY CHAIN OF
ANTIGEN BINDING
FRAGMENT, FAB
LIGHT CHAIN OF
ANTIGEN BINDING
FRAGMENT, FAB

(Rattus
norvegicus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE A 189
VAL B 216
VAL B 166
PRO B 135
PHE B 161
 None
 1.41A 3nbrA-4yo0A:
undetectable		 3nbrA-4yo0A:
24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zs7 LLAMA FAB FRAGMENT
68F2 HEAVY CHAIN
LLAMA FAB FRAGMENT
68F2 LIGHT CHAIN

(Lama glama) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 175
SER L 179
VAL L 150
VAL L 148
PHE L 143
 None
 1.30A 3nbrA-4zs7H:
undetectable		 3nbrA-4zs7H:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a55 ENDO-ALPHA-N-ACETYLG
ALACTOSAMINIDASE

(Streptococcus
pneumoniae) 		PF12905
(Glyco_hydro_101)
PF17451
(Glyco_hyd_101C) 		5 SER A 449
PHE A 347
VAL A 410
PRO A 348
PHE A 421
 None
 1.50A 3nbrA-5a55A:
1.9		 3nbrA-5a55A:
8.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5awn HEAVY CHAIN OF
3BC176 FAB
LIGHT CHAIN OF
3BC176 FAB

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.42A 3nbrA-5awnH:
undetectable		 3nbrA-5awnH:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eor ANTI VACCINIA VIRUS
A27 ANTIBODY 8E3
HEAVY CHAIN
ANTI VACCINIA VIRUS
A27 ANTIBODY 8E3
LIGHT CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 169
VAL L 204
VAL L 154
PRO L 123
PHE L 149
 None
 1.48A 3nbrA-5eorH:
undetectable		 3nbrA-5eorH:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f89 CAP248-2B HEAVY
CHAIN
CAP248-2B LIGHT
CHAIN

(Homo sapiens) 		no annotation 5 PHE H 166
VAL L 196
VAL L 145
PRO L 114
PHE L 140
 None
 1.44A 3nbrA-5f89H:
undetectable		 3nbrA-5f89H:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fji BETA-GLUCOSIDASE

(Aspergillus
fumigatus) 		PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like) 		5 SER A 452
VAL A  74
PHE A 100
PRO A 301
PHE A 306
 EDO  A1881 ( 3.8A)
None
EDO  A1873 ( 4.0A)
None
EDO  A1882 (-4.0A)
 1.38A 3nbrA-5fjiA:
undetectable		 3nbrA-5fjiA:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fjj BETA-GLUCOSIDASE

(Aspergillus
oryzae) 		PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like) 		5 SER A 452
VAL A  75
PHE A 100
PRO A 301
PHE A 306
 PEG  A6002 ( 4.5A)
None
None
None
None
 1.35A 3nbrA-5fjjA:
undetectable		 3nbrA-5fjjA:
10.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ilt BOVINE FAB A01 HEAVY
CHAIN
BOVINE FAB A01 LIGHT
CHAIN

(Bos taurus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE H 219
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.39A 3nbrA-5iltH:
undetectable		 3nbrA-5iltH:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j13 ANTI-TSLP
FAB-FRAGMENT, HEAVY
CHAIN
ANTI-TSLP
FAB-FRAGMENT, LIGHT
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE C 178
VAL B 200
VAL B 149
PRO B 118
PHE B 144
 None
 1.44A 3nbrA-5j13C:
undetectable		 3nbrA-5j13C:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ocy ACPA E4 FAB FRAGMENT
- HEAVY CHAIN
ACPA E4 FAB FRAGMENT
- LIGHT CHAIN

(Homo sapiens) 		no annotation 5 PHE H 173
VAL L 199
VAL L 148
PRO L 117
PHE L 143
 None
 1.39A 3nbrA-5ocyH:
undetectable		 3nbrA-5ocyH:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ogl UNDECAPRENYL-DIPHOSP
HOOLIGOSACCHARIDE--P
ROTEIN
GLYCOTRANSFERASE

(Campylobacter
lari) 		no annotation 5 TYR A 153
SER A  82
PHE A  99
PHE A  80
MET A 106
 None
 1.43A 3nbrA-5oglA:
undetectable		 3nbrA-5oglA:
10.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t4z ANTIBODY DH501 FAB
HEAVY CHAIN
ANTIBODY DH501 FAB
LIGHT CHAIN

(Macaca mulatta) 		no annotation 5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.39A 3nbrA-5t4zH:
undetectable		 3nbrA-5t4zH:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bck N49P7 FAB HEAVY
CHAIN OF N29P7 IGG
N49P7 FAB LIGHT
CHAIN FROM N49P7 IGG

(Homo sapiens) 		no annotation 5 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
 None
 1.48A 3nbrA-6bckH:
undetectable		 3nbrA-6bckH:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gh2 LAMINARIBIOSE
PHOSPHORYLASE

(Paenibacillus
sp. YM1) 		no annotation 5 PHE A 235
VAL A 248
PHE A  77
VAL A 249
PRO A 245
 None
 1.40A 3nbrA-6gh2A:
undetectable		 3nbrA-6gh2A:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
8fab IGG1-LAMBDA HIL FAB
(HEAVY CHAIN)
IGG1-LAMBDA HIL FAB
(LIGHT CHAIN)

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE B 174
SER A 175
VAL A 146
VAL A 144
PHE A 139
 None
 1.35A 3nbrA-8fabB:
undetectable		 3nbrA-8fabB:
19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
8fab IGG1-LAMBDA HIL FAB
(HEAVY CHAIN)
IGG1-LAMBDA HIL FAB
(LIGHT CHAIN)

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 PHE B 174
VAL A 195
VAL A 144
PRO A 113
PHE A 139
 None
 1.43A 3nbrA-8fabB:
undetectable		 3nbrA-8fabB:
19.64